Literature DB >> 10078923

Sampling of grossly benign breast reexcisions: a multidisciplinary approach to assessing adequacy.

S C Abraham1, K Fox, D Fraker, L Solin, C Reynolds.   

Abstract

The widespread use of breast-conserving therapy in the treatment of early-stage breast cancer has resulted in increasing numbers of reexcision specimens requiring histologic assessment for residual disease and margin status. Because many reexcisions are performed for only microscopically positive or close margins, reexcision specimens often appear grossly negative and directed tissue sampling cannot be performed. The issue of adequate sampling in these specimens has not been addressed in the literature. A multidisciplinary approach to identifying the clinically important lesions in breast reexcisions and a cost-effective approach to tissue sampling are needed. We reviewed 97 consecutive cases of grossly negative breast reexcisions in which all tissue had been embedded. Forty-seven specimens contained residual invasive or in situ carcinoma and 50 were histologically negative. Detailed histologic findings were presented to a medical oncologist, a radiation oncologist, and a surgeon, who assessed the clinical impact of each diagnosis. Of the 47 positive specimens, 30 resulted in a major change in patient management (recommendation for additional surgery), 10 resulted in minor changes (alteration in radiation dose or adjuvant chemotherapy regimen), and 7 did not alter management. A total of 1867 blocks were submitted. If one block per centimeter of maximal tissue dimension had been submitted and the remainder of the specimen examined only if initial sections revealed invasive or in situ carcinoma, then 901 blocks would have been processed (52% reduction), but we would have missed an average of 3.7 cases resulting in a major change in therapy, and 3.3 cases resulting in a minor change. In contrast, two blocks per centimeter would have missed an average of less than one case each of diagnoses resulting in major and minor therapy changes (0.9 and 0.8 cases, respectively), and 315 (17%) fewer tissue blocks would have been processed. We recommend submitting two blocks per centimeter in grossly benign reexcisions, and examining the remainder of the tissue only if carcinoma is detected on initial sections.

Entities:  

Mesh:

Year:  1999        PMID: 10078923     DOI: 10.1097/00000478-199903000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Labeling of active proteases in fresh-frozen tissues by topical application of quenched activity-based probes.

Authors:  Nimali P Withana; Megan Garland; Martijn Verdoes; Leslie O Ofori; Ehud Segal; Matthew Bogyo
Journal:  Nat Protoc       Date:  2015-12-30       Impact factor: 13.491

2.  Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease.

Authors:  Brian Madajewski; Brendan F Judy; Anas Mouchli; Veena Kapoor; David Holt; May D Wang; Shuming Nie; Sunil Singhal
Journal:  Clin Cancer Res       Date:  2012-08-29       Impact factor: 12.531

Review 3.  The status of contemporary image-guided modalities in oncologic surgery.

Authors:  Eben L Rosenthal; Jason M Warram; Kirby I Bland; Kurt R Zinn
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

Review 4.  Chemotherapeutic nanomaterials in tumor boundary delineation: Prospects for effective tumor treatment.

Authors:  Ozioma Udochukwu Akakuru; Zhoujing Zhang; M Zubair Iqbal; Chengjie Zhu; Yewei Zhang; Aiguo Wu
Journal:  Acta Pharm Sin B       Date:  2022-02-23       Impact factor: 14.903

5.  Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe.

Authors:  Lei Xi; Guangyin Zhou; Ning Gao; Lily Yang; David A Gonzalo; Steven J Hughes; Huabei Jiang
Journal:  Ann Surg Oncol       Date:  2014-02-20       Impact factor: 5.344

Review 6.  Nanotechnology applications in surgical oncology.

Authors:  Sunil Singhal; Shuming Nie; May D Wang
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

7.  uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.

Authors:  Lily Yang; Hari Krishna Sajja; Zehong Cao; Weiping Qian; Laura Bender; Adam I Marcus; Malgorzata Lipowska; William C Wood; Y Andrew Wang
Journal:  Theranostics       Date:  2013-12-17       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.